Skip to Content

LPZ 15 ap (Lansoprazole Delayed-Release 15 mg)

Pill with imprint LPZ 15 ap is Blue & Pink, Capsule-shape and has been identified as Lansoprazole Delayed-Release 15 mg. It is supplied by Ajanta Pharma Limited.

Lansoprazole is used in the treatment of barrett's esophagus; duodenal ulcer; duodenal ulcer prophylaxis; gerd; erosive esophagitis and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Lansoprazole 15 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for LPZ 15 ap

Lansoprazole Delayed-Release

Imprint
LPZ 15 ap
Strength
15 mg
Color
Blue & Pink
Size
16.00 mm
Shape
Capsule-shape
Availability
Rx and/or OTC
Drug Class
Proton pump inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Ajanta Pharma Limited
National Drug Code (NDC)
27241-0019
Inactive Ingredients
sucrose, methacrylic acid - ethyl acrylate copolymer (1:1) type a, low substituted hydroxypropyl cellulose, magnesium carbonate, magnesium silicate, polyethylene glycol, hydroxypropyl cellulose (type h), silicon dioxide, hypromelloses, ferric oxide red, ferrosoferric oxide, ferric oxide yellow, sodium bicarbonate, sodium lauryl sulfate, shellac, propylene glycol, ammonia, potassium hydroxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.